Reported side effects in human anecdotal use are generally mild and may include: Mild nausea, particularly with oral administration Redness, itching, or irritation at the injection site Temporary dizziness or mild headache Changes in appetite or weight A significant theoretical concern revolves around its pro-angiogenic properties
The peptide has advanced to multicenter clinical trials, making it one of the most advanced peptide-based eczema therapies currently in development
Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway
If theyre not destroyed quickly, degraded or malfunctioning cells can turn into things like cancer or cause inflammation
Withdrawal: Remove needle at the same angle it entered
The proportions of M1M6 and [ 3 H]BPC157 in plasma radioactive components at different sampling times demonstrated that [ 3 H]BPC157 was the main plasma component at 0.05 h (3 min) after administration and was subsequently degraded into small molecular peptide fragments in the following 0.167 h (10 min) (Figure 5A)